EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oligodendroglia vulnerability in the human dorsal striatum in Parkinson’s disease

Juan M Barba-Reyes, Lisbeth Harder, Sergio Marco Salas, Methasit Jaisa-Aad, Clara Muñoz-Castro, Leonardo D Garma, Nima Rafati, Mats Nilsson, Bradley T Hyman, Alberto Serrano-Pozo, Ana B Muñoz-Manchado

Acta Neuropathologica · 05.05.2025 · 149 (1)

DOI: 10.1007/s00401-025-02884-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, online erschienen am 05.05.2025. Verfasst von Juan M Barba-Reyes und 10 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Cell Biology, Department of Neuroscience, Institute for Biomedical Research and Innovation of Cádiz (INiBICA), University of Cádiz, Cádiz, Sp…. Hauptthemen laut MEDLINE: Oligodendroglia, Parkinson Disease, Corpus Striatum. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, NIA NIH HHS, European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oligodendroglia are the responsible cells for myelination in the central nervous system and their involvement in Parkinson’s disease (PD) is poorly understood. We performed sn-RNA-seq and image-based spatial transcriptomics of human caudate nucleus and putamen (dorsal striatum) from PD and control brain donors to elucidate the diversity of oligodendroglia and how they are affected by the disease. We profiled a total of ~ 200.000 oligodendroglial nuclei, defining 15 subclasses, from precursor to mature cells, 4 of which are disease-associated. These PD-specific populations are characterized by the overexpression of heat shock proteins, as well as distinct expression signatures related to immune responses, myelination alterations, and disrupted cell signaling pathways. We have also identified impairments in cell communication and oligodendrocyte development, evidenced by changes in neurotransmitter receptors expression and cell adhesion molecules. In addition, we observed significant disruptions in oligodendrocyte development, with aberrant differentiation trajectories and shifts in cell proportions, particularly in the transition from mature oligodendrocytes to disease-associated states. Quantitative immunohistochemical analysis revealed decreased myelin levels in the PD striatum, which correlated with transcriptomic alterations. Furthermore, spatial transcriptomics mapping revealed the distinct localization of disease-associated populations within the striatum, with evidence of impaired myelin integrity. Thus, we uncover oligodendroglia as a critical cell type in PD and a potential new therapeutic target for myelin-based interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OligodendrogliaParkinson DiseaseCorpus StriatumHumansMaleFemaleAgedMiddle AgedMyelin SheathTranscriptomePutamen

Stichwörter der Autor:innen

MyelinNeurodegenerationOligodendrocyteSc-RNA-seqSpatial transcriptomicsStriatum

Autor:innen und Institutionen

  • Unit of Cell Biology, Department of Neuroscience, Institute for Biomedical Research and Innovation of Cádiz (INiBICA), University of Cádiz, Cádiz, Spain.
  • Laboratory of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
  • Institute of Computational Biology, Computational Health Center, Helmholtz, Munich, Germany.
  • Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
  • Harvard Medical School, Boston, MA, USA.

Förderung

  • Swedish Research Council
  • NIA NIH HHS
  • European Regional Development Fund
  • US National Institute on Aging
  • Swedish Foundation for Strategic Research
  • RyC programme
  • Ministerio de Ciencia e Innovación
  • Prince Mahidol Award Youth Program

Zitieren

APA

Barba-Reyes, J. M., Harder, L., Marco Salas, S., Jaisa-Aad, M., Muñoz-Castro, C., Garma, L. D., Rafati, N., Nilsson, M., Hyman, B. T., Serrano-Pozo, A., & Muñoz-Manchado, A. B. (2025). Oligodendroglia vulnerability in the human dorsal striatum in Parkinson’s disease. Acta Neuropathologica, 149(1). https://doi.org/10.1007/s00401-025-02884-5

Vancouver

Barba-Reyes JM, Harder L, Marco Salas S, Jaisa-Aad M, Muñoz-Castro C, Garma LD, et al. Oligodendroglia vulnerability in the human dorsal striatum in Parkinson’s disease. Acta Neuropathologica. 2025;149(1). doi:10.1007/s00401-025-02884-5

BibTeX
@article{BarbaReyes2025,
  author = {Barba-Reyes, Juan M and Harder, Lisbeth and Marco Salas, Sergio and Jaisa-Aad, Methasit and Muñoz-Castro, Clara and Garma, Leonardo D and Rafati, Nima and Nilsson, Mats and Hyman, Bradley T and Serrano-Pozo, Alberto and Muñoz-Manchado, Ana B},
  title = {Oligodendroglia vulnerability in the human dorsal striatum in Parkinson’s disease},
  journal = {Acta Neuropathologica},
  year = {2025},
  volume = {149},
  number = {1},
  doi = {10.1007/s00401-025-02884-5}
}
Kostenlos starten →